Biotech Growth Trust Balance Sheet Health
Financial Health criteria checks 3/6
Biotech Growth Trust has a total shareholder equity of £293.4M and total debt of £11.4M, which brings its debt-to-equity ratio to 3.9%. Its total assets and total liabilities are £308.2M and £14.8M respectively.
Key information
3.9%
Debt to equity ratio
UK£11.44m
Debt
Interest coverage ratio | n/a |
Cash | UK£3.13m |
Equity | UK£293.42m |
Total liabilities | UK£14.79m |
Total assets | UK£308.21m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BIOG's short term assets (£4.4M) do not cover its short term liabilities (£14.8M).
Long Term Liabilities: BIOG has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: BIOG's net debt to equity ratio (2.8%) is considered satisfactory.
Reducing Debt: BIOG's debt to equity ratio has reduced from 8.7% to 3.9% over the past 5 years.
Debt Coverage: BIOG's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if BIOG's interest payments on its debt are well covered by EBIT.